These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 6442741

  • 1. [Clinical study on the effect of human lymphoblastoid interferon in B-cell malignancies].
    Takeyama H, Yano K, Kataoka T, Watanabe E, Kobayashi M, Ohno R.
    Rinsho Ketsueki; 1984 Dec; 25(12):1921-7. PubMed ID: 6442741
    [No Abstract] [Full Text] [Related]

  • 2. [Plasmapheresis in the treatment of paraproteinemic hemoblastoses].
    Ryzhko VV, Gorodetskiĭ VM.
    Ter Arkh; 1983 Dec; 55(11):70-5. PubMed ID: 6419367
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical efficacy of interferon-beta (MR-21) in hematological malignancies].
    Imamura Y.
    Nihon Gan Chiryo Gakkai Shi; 1987 Jun 20; 22(5):934-41. PubMed ID: 3694002
    [No Abstract] [Full Text] [Related]

  • 4. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
    Ozer H, Gavigan M, O'Malley J, Thompson D, Dadey B, Nussbaum-Blumenson A, Snider C, Rudnick S, Ferraresi R, Norred S.
    J Biol Response Mod; 1983 Jun 20; 2(6):499-515. PubMed ID: 6607323
    [Abstract] [Full Text] [Related]

  • 5. [Clinical study on the effect of human lymphoblastoid interferon in multiple myeloma].
    Takeyama H, Yano K, Kataoka T, Yamamoto M, Emi N, Kodera Y, Kawashima K, Ohno R, Yokomaku S, Kobayashi M.
    Gan To Kagaku Ryoho; 1983 Sep 20; 10(9):2043-8. PubMed ID: 6614939
    [Abstract] [Full Text] [Related]

  • 6. [Effects of interferon on various malignancies].
    Taguchi T.
    Gan To Kagaku Ryoho; 1984 Feb 20; 11(2):194-204. PubMed ID: 6696457
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of hematological malignancies with recombinant leukocyte A interferon (rIFN-alpha A)].
    Ohno R, Kodera Y, Ogura M, Murase T, Emi N, Okumura M, Morishita Y, Nagura E, Minami S, Morishima Y.
    Gan To Kagaku Ryoho; 1984 Dec 20; 11(12 Pt 1):2531-6. PubMed ID: 6594973
    [Abstract] [Full Text] [Related]

  • 8. [Clinical and immunological studies of human fibroblast interferon and human lymphoblastoid interferon in malignant diseases].
    Ezaki K.
    Gan No Rinsho; 1983 May 20; 29(6):598-602. PubMed ID: 6308306
    [No Abstract] [Full Text] [Related]

  • 9. DC-based immunotherapy of B-cell malignancies.
    Reichardt VL, Brossart P.
    Cytotherapy; 2004 May 20; 6(1):62-7. PubMed ID: 14985168
    [Abstract] [Full Text] [Related]

  • 10. [Clinical effects of human lymphoblastoid interferon in patients with hematologic neoplasms].
    Oda Y, Irie S, Inagaki M, Fukumoto M, Ueda I, Ohmoto E, Fujimoto S, Endo Y, Watanabe S, Lai M, Takahashi I, Kimura I, Ishii H, Sezaki T.
    Gan To Kagaku Ryoho; 1983 May 20; 10(5):1313-9. PubMed ID: 6575725
    [Abstract] [Full Text] [Related]

  • 11. [Clinical effect of human lymphoblastoid interferon in patients with multiple myeloma].
    Yoshida M, Ohta M, Muroi K, Takeda K, Kitagawa S, Tsuboyama A, Sakamoto S, Miura Y, Mutoh Y.
    Gan To Kagaku Ryoho; 1984 Jul 20; 11(7):1394-8. PubMed ID: 6742866
    [Abstract] [Full Text] [Related]

  • 12. [Phase II study of recombinant leukocyte A interferon (Ro 22-8181) in hematological malignancies].
    Gan To Kagaku Ryoho; 1985 Apr 20; 12(4):928-35. PubMed ID: 3885864
    [Abstract] [Full Text] [Related]

  • 13. Treatment of lymphoid neoplasias with interferon. I. Human fibroblastic beta-interferon in malignant gammapathies. Phase II trial.
    Misset JL, Mathé G, Gastiaburu J, Goutner A, Dorval T, Gouveia J, Hayat M, Jasmin C, Schwarzenberg L, Machover D, Ribaud P, De Vassal F, Horoszewicz JS.
    Anticancer Res; 1982 Apr 20; 2(1-2):63-6. PubMed ID: 6180675
    [Abstract] [Full Text] [Related]

  • 14. An association between renal cell carcinoma and lymphoid malignancies. A case series of eight patients.
    Nishikubo CY, Kunkel LA, Figlin R, Belldegrun A, Rosen P, Elashoff R, Wang H, Territo MC.
    Cancer; 1996 Dec 01; 78(11):2421-6. PubMed ID: 8941014
    [Abstract] [Full Text] [Related]

  • 15. Treatment of plasma cell neoplasm with recombinant leukocyte A interferon and human lymphoblastoid interferon.
    Ohno R, Kodera Y, Ogura M, Murase T, Emi N, Okumura M, Morishita Y, Nagura E, Minami S, Morishima Y.
    Cancer Chemother Pharmacol; 1985 Dec 01; 14(1):34-7. PubMed ID: 3917376
    [Abstract] [Full Text] [Related]

  • 16. Clinical uses for interferon in the treatment of cancer. A critical review.
    Ringenberg QS, Patterson WP.
    Mo Med; 1988 Jan 01; 85(1):21-6. PubMed ID: 3277031
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Alpha interferon and lymphoid hemopathies].
    Flandrin G.
    Ann Med Interne (Paris); 1989 Jan 01; 139(8):530-3. PubMed ID: 2729810
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.